诺和诺德裁员9000人,默沙东关闭伦敦研发业务,礼来中国架构调整

医药经济报
Sep 11

1.诺和诺德全球裁员9000人9月10日,诺和诺德宣布进行全公司范围的转型,旨在精简组织架构,提高决策速度,并将资源重新配置,以促进公司在糖尿病和肥胖症领域的增长。作为转型的一部分,诺和诺德计划在全球裁员约9000人,公司现有78400个职位,其中丹麦预计将裁员约5000人。此次转型体现了诺和诺德致力于满足不断增长的全球需求,同时也致力于在更具活力、以消费者为导向的肥胖症市场中竞争,近期的增长放缓...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10